To investigate whether the enzyme inhibitory properties of SHR8443 translate into modulation of the PI3K/mTOR signaling pathway, we assessed the phosphorylation status of downstream substrates in tumor cell lines with different genetic backgrounds. This evidence concerns the gene MTOR and neoplasm.